110 related articles for article (PubMed ID: 1949848)
21. Clinical and biological activity of the interferons in hematologic malignancies.
Gutterman JU
Prog Clin Biol Res; 1989; 288():337-48. PubMed ID: 2470111
[No Abstract] [Full Text] [Related]
22. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1996; 16():347-75. PubMed ID: 8639390
[No Abstract] [Full Text] [Related]
23. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
[TBL] [Abstract][Full Text] [Related]
24. Update on therapeutic options for chronic myelogenous leukemia.
Talpaz M; Kantarjian H; Kurzrock R; Gutterman JU
Semin Hematol; 1990 Jul; 27(3 Suppl 4):31-6. PubMed ID: 2197731
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
[TBL] [Abstract][Full Text] [Related]
26. Combination therapy for chronic myelogenous leukemia with interferon alfa and other cytokines.
Kloke O
Semin Hematol; 1993 Jul; 30(3 Suppl 3):22-3. PubMed ID: 8235699
[No Abstract] [Full Text] [Related]
27. Hematopoietic growth factors in myelodysplastic syndromes.
Blinder VS; Roboz GJ
Curr Hematol Rep; 2003 Nov; 2(6):453-8. PubMed ID: 14561388
[TBL] [Abstract][Full Text] [Related]
28. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1988; 10():129-47. PubMed ID: 3079381
[No Abstract] [Full Text] [Related]
29. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H
Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088
[TBL] [Abstract][Full Text] [Related]
30. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
31. Leukemia and myelomatosis.
Catovsky D
Cancer Chemother Biol Response Modif; 1987; 9():134-64. PubMed ID: 3079401
[No Abstract] [Full Text] [Related]
32. [Indications, technique and risks in bone marrow transplantation in adulthood].
Heyll A; Söhngen D; Minning H; Meckenstock G; Aul C; Schneider W
Praxis (Bern 1994); 1996 Mar; 85(12):378-86. PubMed ID: 8643901
[TBL] [Abstract][Full Text] [Related]
33. [Interferon alpha in the treatment of chronic myeloid leukemia].
Tóthová E; Fricová M; Stecová N; Svorcová E; Surová M; Kafková A; Guman T; Mudronová B
Vnitr Lek; 1996 May; 42(5):327-30. PubMed ID: 8768291
[TBL] [Abstract][Full Text] [Related]
34. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
[TBL] [Abstract][Full Text] [Related]
35. Recombinant interferon beta in chronic myelogenous leukemia.
Aulitzky WE; Després D; Rudolf G; Aman J; Peschel C; Huber C
Semin Hematol; 1993 Jul; 30(3 Suppl 3):14-6. PubMed ID: 7694372
[No Abstract] [Full Text] [Related]
36. Autologous blood stem-cell transplantation and recombinant interferon alfa in chronic myeloid leukemia.
Reiffers J; Montastruc M; Cahn JY; Souillet G; Troncy J; Leblond V; Caillot D; Troussard X; Marit G; Fabères C
Semin Hematol; 1993 Jul; 30(3 Suppl 3):51-2. PubMed ID: 8235709
[No Abstract] [Full Text] [Related]
37. Replication errors in hematological neoplasias: genomic instability in progression of disease is different among different types of leukemia.
Ohyashiki JH; Ohyashiki K; Aizawa S; Kawakubo K; Shimamoto T; Iwama H; Hayashi S; Toyama K
Clin Cancer Res; 1996 Sep; 2(9):1583-9. PubMed ID: 9816337
[TBL] [Abstract][Full Text] [Related]
38. Biologic therapy of chronic myelogenous leukemia.
Kantarjian HM; Talpaz M; Gutterman J
Oncology (Williston Park); 1987 Sep; 1(7):35-40, 48-9, 52. PubMed ID: 3152810
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years.
Kantarjian H; O'Brien S; Cortes J; Wierda W; Faderl S; Garcia-Manero G; Issa JP; Estey E; Keating M; Freireich EJ
Cancer; 2008 Oct; 113(7 Suppl):1933-52. PubMed ID: 18798533
[TBL] [Abstract][Full Text] [Related]
40. Recombinant human gamma interferon administered by continuous intravenous infusion in acute myelogenous leukemia and myelodysplastic syndromes.
Stone RM; Spriggs DR; Arthur KA; Mayer RJ; Griffin J; Kufe DW
Am J Clin Oncol; 1993 Apr; 16(2):159-63. PubMed ID: 8452111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
